Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. A phase 3 trial found that a new meningococcal disease vaccine is ...

Phase-three trials show the NmCV-5 vaccine can illicit an immune response against the five main strains of meningococcal bacteria. Results show immune response from one dose of NmCV-5 was notably ...

Please provide your email address to receive an email when new articles are posted on . A pentavalent vaccine against meningitis continued to show promise in a phase 3 trial in Africa’s meningitis ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

An effective, affordable, multivalent meningococcal conjugate vaccine is needed to prevent epidemic meningitis in the African meningitis belt. Data on the safety and immunogenicity of NmCV-5, a ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

Dr. Samba O. Sow, Director General of CVD-Mali, has led efforts to eradicate meningococcal disease in the African Meningitis Belt for more than a decade. University of Maryland School of Medicine ...

In a recent study published in The New England Journal of Medicine, researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine compared to the World Health ...

A trial of a new vaccine against meningococcal disease, a cause of meningitis and blood poisoning, has found that it is safe and induces a strong immune response across five strains of meningococcal ...

Neisseria meningitidis serogroups A, B, C, W, X, and Y cause outbreaks of meningococcal disease. Quadrivalent conjugate vaccines targeting the A, C, W, and Y serogroups are available. A pentavalent ...